Clinical Trials Directory

Trials / Completed

CompletedNCT02231203

Effect of Omega-3 Fatty Acids on the Perioperative Immune Response and Erythrocyte Function

Effect of Intravenous Omega-3 Fatty Acids on the Perioperative Immune Response and Erythrocyte Function in Patients With Colon Cancer

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Medical Center Alkmaar · Academic / Other
Sex
All
Age
60 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Ideally, the postoperative inflammatory response is part of a well-orchestrated mechanism that contributes to tissue healing and rapid recovery. An exaggerated uncontrolled inflammatory response, however may lead to catabolism, tissue damage and organ failure. Omega-3 fatty acids may provide a means to alter cellular immune responses to the benefit of the patient. When omega-3 fatty acids are incorporated into membranes of inflammatory cells, they trigger intracellular signalling pathways that result in a less pro-inflammatory response. They modify gene and protein expression, modulate membrane protein activity and act as a reservoir for bioactive molecules. They also have a strong anti-inflammatory effect by mediating resolution of the inflammation. Furthermore, omega-3 fatty acids improve erythrocyte function, which is vital for an adequate microcirculation, tissue oxygenation and wound healing. The investigators hypothesize that the perioperative administration of intravenous omega-3 fatty acids results in a rapid incorporation in immune cells and erythrocytes, thereby reducing the postoperative inflammatory response and improving erythrocyte function in patients undergoing colorectal surgery.

Conditions

Interventions

TypeNameDescription
DRUGOmegaven2 infusions, 2 ml/kg, one the night before operation and one the day after operation
DRUGPlacebo2 infusions, 2 ml/kg, one the night before operation and one the day after operation

Timeline

Start date
2014-10-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2014-09-04
Last updated
2018-07-31

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02231203. Inclusion in this directory is not an endorsement.